학술논문
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Kang, Yoon-Koo ; Terashima, Masanori ; Kim, Young-Woo ; Boku, Narikazu ; Chung, Hyun Cheol ; Chen, Jen-Shi ; Ji, Jiafu ; Yeh, Ta-Sen ; Chen, Li-Tzong ; Ryu, Min-Hee ; Kim, Jong Gwang ; Omori, Takeshi ; Rha, Sun Young ; Kim, Tae Yong ; Ryu, Keun Won ; Sakuramoto, Shinichi ; Nishida, Yasunori ; Fukushima, Norimasa ; Yamada, Takanobu ; Bai, Li-Yuan ; Hirashima, Yoshinori ; Hagihara, Shunsuke ; Nakada, Takashi ; Sasako, Mitsuru
Source
In The Lancet Gastroenterology & Hepatology August 2024 9(8):705-717
Subject
Language
ISSN
2468-1253
Abstract
Funding Ono Pharmaceutical and Bristol Myers Squibb.